Discontinued — last reported Q2 '18

Non-Current Liabilities

Debt Instrument Face Amount

UnitedHealth Group Debt Instrument Face Amount decreased by 75.0% to $3.00B in Q2 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ2 2018
Last reportedQ2 2018

How to read this metric

An increase indicates higher leverage, while a decrease indicates debt repayment or deleveraging.

Detailed definition

This represents the par or principal value of the company's debt instruments, excluding any premiums, discounts, or issu...

Peer comparison

Standardized across all public companies with debt instruments on their balance sheet.

Metric ID: debt_instrument_face_amount

Historical Data

5 periods
 Q2 '22Q1 '23Q1 '24Q3 '24Q2 '25
Value$6.00B$6.50B$6.00B$12.00B$3.00B
QoQ Change+8.3%-7.7%+100.0%-75.0%
YoY Change-7.7%
Range$3.00B$12.00B
CAGR-50.0%
Avg YoY Growth-7.7%
Median YoY Growth-7.7%

Debt Instrument Face Amount at Other Companies

Frequently Asked Questions

What is UnitedHealth Group's debt instrument face amount?
UnitedHealth Group (UNH) reported debt instrument face amount of $3.00B in Q2 2025.
What does debt instrument face amount mean?
The total principal amount of debt the company is obligated to repay at maturity.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.